GoodRx Holdings Inc (GDRX) Q3 2024 Earnings Call Highlights: Strong Financial Performance ... [Yahoo! Finance]
GoodRx Holdings, Inc. - Class A (GDRX)
Company Research
Source: Yahoo! Finance
Prescription Transactions Revenue: $140.4 million, a 4% increase year over year. Subscription Revenue: Declined 8% to $21.3 million. Pharma Manufacturer Solutions Revenue: $28.1 million, a 77% increase year over year. Net Income: $4.0 million compared to a net loss of $38.5 million in the prior year. Adjusted Net Income: $31.9 million, up from $25.5 million year over year. Adjusted EBITDA: $65.0 million, a 21.5% increase year over year. Adjusted EBITDA Margin: 33.3%, up 520 basis points year over year. Cash and Cash Equivalents: $423.8 million at the end of the quarter. Outstanding Debt: $500 million. Fourth Quarter Revenue Guidance: Approximately $200 million. Pharma Manufacturer Solutions Revenue Growth Guidance: Expected 20% growth in Q4. Warning! GuruFocus has detected 5 Warning Signs with GDRX. Release Date: November 07, 2024 For the complete transcript of the earnings call, please refer to the full earnings call transcript GoodRx Holdings Inc ( NASDA
Show less
Read more
Impact Snapshot
Event Time:
GDRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GDRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GDRX alerts
High impacting GoodRx Holdings, Inc. - Class A news events
Weekly update
A roundup of the hottest topics
GDRX
News
- Which health insurance plan may be right for you? [Yahoo! Finance Canada]Yahoo! Finance Canada
- Which health insurance plan may be right for you? [Yahoo! Finance]Yahoo! Finance
- NCPDP Foundation Shares Insights From a Completed Study Focused on Pharmacy Interoperability [Yahoo! Finance]Yahoo! Finance
- NCPDP Foundation Shares Insights From a Completed Study Focused on Pharmacy InteroperabilityPR Web
- GoodRx Holdings, Inc. (NASDAQ: GDRX) had its price target lowered by analysts at Citigroup Inc. from $10.00 to $7.00. They now have a "buy" rating on the stock.MarketBeat
GDRX
Earnings
- 11/7/24 - Beat
GDRX
Sec Filings
- 11/14/24 - Form SC
- 11/13/24 - Form SC
- 11/12/24 - Form 3
- GDRX's page on the SEC website